Genetic Heritability of Ischemic Stroke and the Contribution of Previously Reported Candidate Gene and Genomewide Associations

  • Steve Bevan
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Matthew Traylor
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Poneh Adib-Samii
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Rainer Malik
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Nicola L. M. Paul
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Caroline Jackson
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Martin Farrall
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Peter M. Rothwell
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Cathie Sudlow
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Martin Dichgans
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...
  • Hugh S. Markus
    From the Stroke and Dementia Research Group, St George’s University of London, London, UK (S.B., M.T., P.A.-S., H.S.M.); the Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich, Germany (R.M., M.D.); the Stroke Prevention Research Unit, Nuffield Department of Neuroscience (N.L.M.P., P.M.R.) and the Department of Cardiovascular Medicine (M.F.), University of Oxford, Oxford, UK (N.L.M.P., P.M.R.); and the Division of Clinical Neurosciences...

説明

<jats:sec> <jats:title>Background and Purpose—</jats:title> <jats:p>The contribution of genetics to stroke risk, and whether this differs for different stroke subtypes, remainsuncertain. Genomewide complex trait analysis allows heritability to be assessed from genomewide association study (GWAS) data. Previous candidate gene studies have identified many associations with stoke but whether these are important requires replication in large independent data sets. GWAS data sets provide a powerful resource to perform replication studies.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods—</jats:title> <jats:p>We applied genomewide complex trait analysis to a GWAS data set of 3752 ischemic strokes and 5972 controls and determined heritability for all ischemic stroke and the most common subtypes: large-vessel disease, small-vessel disease, and cardioembolic stroke. By systematic review we identified previous candidate gene and GWAS associations with stroke and previous GWAS associations with related cardiovascular phenotypes (myocardial infarction, atrial fibrillation, and carotid intima-media thickness). Fifty associations were identified.</jats:p> </jats:sec> <jats:sec> <jats:title>Results—</jats:title> <jats:p> For all ischemic stroke, heritability was 37.9%. Heritability varied markedly by stroke subtype being 40.3% for large-vessel disease and 32.6% for cardioembolic but lower for small-vessel disease (16.1%). No previously reported candidate gene was significant after rigorous correction for multiple testing. In contrast, 3 loci from related cardiovascular GWAS studies were significant: <jats:italic>PHACTR1</jats:italic> in large-vessel disease ( <jats:italic>P</jats:italic> =2.63e <jats:sup>−6</jats:sup> ), <jats:italic>PITX2</jats:italic> in cardioembolic stroke ( <jats:italic>P</jats:italic> =4.78e <jats:sup>−8</jats:sup> ), and <jats:italic>ZFHX3</jats:italic> in cardioembolic stroke ( <jats:italic>P</jats:italic> =5.50e <jats:sup>−7</jats:sup> ). </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>There is substantial heritability for ischemic stroke, but this varies for different stroke subtypes. Previous candidate gene associations contribute little to this heritability, but GWAS studies in related cardiovascular phenotypes are identifying robust associations. The heritability data, and data from GWAS, suggest detecting additional associations will depend on careful stroke subtyping.</jats:p> </jats:sec>

収録刊行物

  • Stroke

    Stroke 43 (12), 3161-3167, 2012-12

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (8)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ